Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Katherine L. Ullman
Advertisement
Katherine L. Ullman is president, KLU Consulting, LLC
Articles by Katherine L. Ullman
Advertisement
Latest Updated Articles
Understanding Concomitant Components in Pharmaceutical ExcipientsPublished: February 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
2
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
3
Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One
4
Sustainability and Stability in Excipients
5
